Location: Macon

The purpose of this phase 3 study is to evaluate glycemic control in participants with T2DM who are taking mealtime study insulin LY900014 in combination with long-acting insulin glargine.

Location(s): Macon

Condition: Diabetes

The purpose of this phase 3 study is to evaluate the safety and effects of study tirzepatide on body weight compared to placebo T2DM patients who are overweight or obese.

Location(s): Macon

Condition: Diabetes, Obese/Obesity

The purpose of the study is to evaluate the dose-response efficacy, safety, and pharmacokinetics (PK) of AZD5718 compared to placebo in participants with proteinuric chronic kidney disease (CKD).

Location(s): Macon

Condition: Kidney Disease

This is a phase 2 study evaluating the efficacy and safety of a low and high dose of study LX9211 compared to placebo in patients with moderate to severe diabetic peripheral neuropathy.

Location(s): Jacksonville- LaVilla (Downtown), Lake CIty, Macon

Condition: Diabetic Peripheral Neuropathy

This study is being done to assess the efficacy and safety of tirzepatide compared to dulaglutide in patients with type 2 diabetes and increased cardiovascular risk.

Location(s): Jacksonville- LaVilla (Downtown), Macon

Condition: Diabetes, Heart Disease

A Double-blind Randomized Placebo-controlled Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Atherosclerotic Cardiovascular Disease

Location(s): Jacksonville (Headquarters), Jacksonville- LaVilla (Downtown), Lake CIty, Macon, St. Augustine

Condition: Cholesterol, Heart Disease